<DOC>
	<DOCNO>NCT00310674</DOCNO>
	<brief_summary>Immunogenicity , Safety Tolerability , Chiron Meningococcal C Conjugate Vaccine Administered Healthy Premature Non Premature Children 3 month age</brief_summary>
	<brief_title>Immunogenicity , Safety Tolerability , Chiron Meningococcal C Conjugate Vaccine Administered Healthy Premature Non Premature Children 3 Months Age</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child 11 15 week age Children previously receive kind Meningococcal C vaccine , DTaPIPVHBVHib vaccine Hepatitis B vaccine birth Children previous ascertain suspected disease cause N. meningitidis , Corynebacterium diphtheriae , Clostridium tetani , poliovirus , Hepatitis B H. influenzae type b , culture proven Bordetella pertussis , clinical condition spasmodic cough period longer equal 2 week associate apnea whoop Children household contact and/or intimate exposure individual culture prove N. meningitidis serogroup C Bordetella pertussis , within previous 60 day</criteria>
	<gender>All</gender>
	<minimum_age>11 Weeks</minimum_age>
	<maximum_age>15 Weeks</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Prevention Meningococcal Meningitis</keyword>
	<keyword>meningococcal vaccine</keyword>
	<keyword>conjugate</keyword>
	<keyword>Immunology</keyword>
	<keyword>infant</keyword>
</DOC>